Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver disease (2021)
Attributed to:
Expansion of the Metabolomic and Cardiovascular Disease Facility at Cambridge University
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.02.09.21251354
Publication URI: http://dx.doi.org/10.1101/2021.02.09.21251354
Type: Preprint